News
BioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunology
A German independent research institute, BioMed X, announces the start of its new research project ‘Regulatory T Cell Dysfunction in Autoimmunity and Inflammaging’ (TDA) in collaboration with Merck KGaA, Darmstadt, Germany. The main objective of the research group TDA...
News
Early Breast Cancer Treatment Lynparza Now Has FDA Approval
The FDA approved the AstraZeneca and Merck medications for a select subset of individuals with severe early-stage breast cancer, after chemotherapy before or after surgery. The patient's tumour must have BRCA mutations in the germline and be HER2-negative. According to...
News
Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
On May 17th, 500+ of pharma’s clinical innovation will come together for the home of clinical collaboration, Reuters Events: Pharma Clinical 2022,to set new standards in digital and patient innovation for clinical transformation.
The catalyst for this has been the...
News
Emmes Acquires Casimir, Its Fourth Major Acquisition
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that it has acquired Casimir, a U.S.-based CRO. Casimir has experience in more than 20 rare diseases and has...
News
Food Poisoning Medication And Treatment: A Brief Guide
Food poisoning occurs when harmful pathogens such as parasites, toxins, bacteria, or viruses contaminate food and cause illness. The terms foodborne disease or foodborne illness are used interchangeably to describe the condition. Patients may feel irritation, infection, or inflammation...
News
COVID-19 May Have A Novel Treatment, According To Scientist
Cedars-Sinai researchers have discovered a potential new COVID-19 treatment: a biologic material made from reengineered cell cultures. When tested in human lung cells, scientists discovered that the chemical blocked SARS-CoV-2, the causative agent of COVID-19, from replicating and also...
News
Japan tops CPhI API Quality ranking for second year
CPhI Japan 2022 returns as a SMART event – with live exhibition at the Big Sight Exhibition Center in Tokyo (20-22 April) alongside an online networking platform – as CPhI data confirms the country continues to top global ‘API...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read